FDA approves new Omnipod insulin pump model in USA
BEDFORD, MA–(Marketwire – Dec 14, 2012) – Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology, today announced that the Company has received
BEDFORD, MA–(Marketwire – Dec 14, 2012) – Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology, today announced that the Company has received
There’s something fishy about the latest issue of the online magazine as we investigate the relevance of omega 3 oils in the modern diet. There’s
Teva Pharmaceutical Industries Ltd. (TEVA), the world’s largest generic-drug maker, is seeking to transform a compound once rejected by Sanofi into the first treatment to
The Injex30 is a needle-free device which is approved by the NHS, FDA and has CE approval. It gives insulin users a real alternative to
The NovoPen Echo is Novo Nordisk’s latest insulin pen and it’s especially designed to meet the needs of children. not only does it deliver in
Insulin pens that have been a feature of diabetes management since their release twenty years ago. Timesulin — an innovative ‘smart cap’ for insulin pens